Nicotinell Cool Mint (Nicotine Polacrilex)

Nicotinell Cool Mint, a nicotine replacement therapy, is used in smoking cessation to manage nicotine dependence.

• Smoking cessation: assists adult smokers in reducing cravings and withdrawal symptoms during quit attempts.
• Tobacco dependence: provides a controlled nicotine dose to facilitate gradual reduction of tobacco use.
• Relapse prevention: helps maintain abstinence after quitting by mitigating occasional urges.

• Nicotine Polacrilex is a nicotine salt bound to a polymer matrix that releases nicotine slowly when placed in the mouth. The released nicotine binds to nicotinic acetylcholine receptors in the brain, acting as a partial agonist that reduces the intensity of withdrawal and cravings while allowing the smoker to taper nicotine exposure gradually.

Common Side Effects

• Mouth irritation: mild soreness or tingling in the oral cavity.
• Throat irritation: transient scratchy feeling.
• Nausea: occasional upset stomach.
• Headache: mild to moderate intensity.
• Dizziness: brief light‑headed sensation.
• Hiccups: intermittent bouts.

Serious or Rare Side Effects

• Allergic reaction: rash, swelling, or difficulty breathing.
• Cardiovascular events: chest pain, palpitations, or hypertension.
• Severe hypotension: marked drop in blood pressure.
• Arrhythmia: irregular heart rhythm.
• Mouth ulceration: persistent sores in the oral mucosa.
• Respiratory distress: wheezing or severe shortness of breath.

Before using Nicotinell Cool Mint, consider the following precautions:

• Cardiovascular assessment: evaluate recent heart attack or uncontrolled hypertension.
• Medical supervision: use under guidance of a healthcare professional.
• Non‑smoker restriction: not intended for individuals who do not currently smoke.
• Pregnancy and lactation: discuss risks with a clinician before use.
• Child safety: keep product out of reach of children.
• Store at ambient temperature below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Nicotinell Cool Mint may interact with other medicines as follows:

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive crisis.
• Certain antihypertensive agents (e.g., beta‑blockers): additive cardiovascular effects.
• Antidepressants that affect nicotine metabolism: potential for altered nicotine levels.

Moderate Interactions (Monitor Closely)

• Caffeine‑containing products: may enhance stimulant effects such as jitteriness.
• Warfarin: nicotine can affect INR stability; monitor coagulation parameters.
• Antipsychotics metabolized by CYP2D6: nicotine may induce enzyme activity, reducing drug efficacy.